Clinical Outcomes and Prognostic Implications of TAVR in Patients With Active Cancer: A Meta-Analysis

  • 0Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

|

|

Summary

This summary is machine-generated.

Transcatheter aortic valve replacement (TAVR) is safe for cancer patients in the short term. However, active cancer patients experience significantly higher long-term mortality after TAVR for severe aortic stenosis.

Area Of Science

  • Cardiovascular Medicine
  • Oncology
  • Interventional Cardiology

Background

  • Transcatheter aortic valve replacement (TAVR) is a key treatment for severe aortic stenosis (AS) in high-risk patients.
  • Clinical outcomes of TAVR in patients with active cancer are not well-established.
  • This study investigates TAVR outcomes in patients with and without active cancer.

Purpose Of The Study

  • To evaluate procedural success, complications, and survival rates of TAVR in patients with active cancer compared to those without.
  • To determine the prognostic implications of active cancer on TAVR outcomes.
  • To inform clinical decision-making for this complex patient group.

Main Methods

  • A systematic literature search was performed across major scientific databases (PubMed, Scopus, Web of Science).
  • A meta-analysis using a random-effects model was conducted to synthesize data.
  • Statistical analyses were performed using STATA version 18.0.

Main Results

  • No significant differences in in-hospital or 30-day mortality were observed between cancer and non-cancer patients.
  • 1-year and 2-year mortality rates were significantly higher in patients with active cancer.
  • Major bleeding, acute kidney injury, stroke, and permanent pacemaker implantation rates did not differ significantly between groups.

Conclusions

  • TAVR provides comparable short-term survival and procedural safety for patients with and without active cancer.
  • Active cancer is associated with significantly increased long-term mortality following TAVR.
  • TAVR is a viable option for cancer patients with severe AS, but requires careful consideration of long-term prognosis and management strategies.

Related Concept Videos

Cancer Survival Analysis 01:21

313

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Cancer Therapies 02:49

7.5K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Vaccines 01:30

310

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies 02:57

7.4K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy 01:27

450

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.